Celiac Disease — Serologic Testing, Biopsy, and Gluten-Free Diet

Celiac disease is a chronic, immune-mediated enteropathy triggered by gluten ingestion in genetically susceptible individuals. It affects the small intestine, leading to villous atrophy, crypt hyperplasia, and increased intraepithelial lymphocytes.

[KEY_CONCEPT] Celiac disease is fundamentally an autoimmune disorder where gluten proteins (gliadin, glutenin) from wheat, barley, and rye trigger an aberrant immune response in genetically predisposed individuals carrying HLA-DQ2 (95%) or HLA-DQ8 (5%) haplotypes.

Epidemiology:

• Prevalence: 1% of the global population
• Genetic predisposition: 95% have HLA-DQ2, 5% have HLA-DQ8
• Gender: Female predominance (2-3:1 ratio)
• Age: Bimodal distribution with peaks in infancy and 4th-5th decades
• Geographic variation: Higher prevalence in Northern Europe and North America

[HIGH_YIELD] Pathophysiology involves a complex interplay between:

1. Genetic susceptibility (HLA-DQ2/DQ8)
2. Environmental trigger (gluten exposure)
3. Immune dysregulation leading to:
   • Tissue transglutaminase 2 (tTG2) cross-linking of gliadin peptides
   • Adaptive immune response with T-cell activation
   • Inflammatory cascade resulting in villous atrophy

Associated Conditions:

• Type 1 diabetes mellitus (5-10% prevalence)
• Autoimmune thyroid disease
• Down syndrome (5-15% prevalence)
• IgA deficiency (2-3% prevalence)
• First-degree relatives (10% prevalence)

Celiac disease presents with a wide spectrum of clinical manifestations, ranging from asymptomatic to severe malabsorption syndrome. The clinical presentation has evolved over recent decades, with non-classical and atypical presentations becoming increasingly recognized.

[CLINICAL_PEARL] Modern celiac disease often presents with subtle, non-gastrointestinal symptoms rather than the classic malabsorption syndrome, particularly in adults.

Classical Presentation (more common in children):

• Gastrointestinal symptoms:
  • Chronic diarrhea with steatorrhea
  • Abdominal distension and cramping
  • Weight loss and failure to thrive
  • Vomiting and decreased appetite

Non-Classical Presentation (more common in adults):

• Iron deficiency anemia (most common presentation in adults)
• Osteoporosis or osteopenia
• Neurological symptoms: peripheral neuropathy, ataxia, headaches
• Dermatological: dermatitis herpetiformis (pathognomonic skin manifestation)
• Reproductive issues: infertility, recurrent pregnancy loss
• Dental enamel defects
• Elevated liver enzymes

[HIGH_YIELD] Atypical/Silent Celiac Disease:

• Asymptomatic patients with positive serology and histology
• Often discovered during family screening or evaluation for associated conditions
• May have subclinical nutritional deficiencies

Extraintestinal Manifestations by System:

[KEY_CONCEPT] Red flags that should prompt celiac disease evaluation:

• Unexplained iron deficiency anemia
• Chronic diarrhea with weight loss
• Family history of celiac disease
• Associated autoimmune conditions
• Dermatitis herpetiformis

[HIGH_YIELD] The diagnosis of celiac disease requires a combination of clinical presentation, positive serology, and confirmatory small bowel biopsy in most cases. However, recent guidelines allow for biopsy-sparing diagnosis in select pediatric cases.

Diagnostic Algorithm:

Suspected Celiac Disease | v Patient on gluten-containing diet? | No --|-- Yes | | Gluten v challenge Check total IgA level for 6-8 | weeks v | IgA sufficient? | | | No --|-- Yes | | | | IgG-based | | testing | | | | v v v Serology --> tTG-IgG tTG-IgA positive? EMA-IgG EMA-IgA | | | No --|-- Yes | | | v v Consider Positive serology? other | diagnosis No --|-- Yes | | Reassess | clinical | suspicion | | v | Small bowel biopsy | | | Marsh 2-3? | | | No --|-- Yes | | | v | v Alternative | Celiac diagnosis | Disease v Consider: - Potential celiac - Seronegative celiac - Alternative diagnosis

Serologic Testing:

[CLINICAL_PEARL] Always check total IgA level first - IgA deficiency occurs in 2-3% of celiac patients and will cause false-negative IgA-based tests.

First-line serology (patient must be on gluten-containing diet):

• Tissue transglutaminase IgA (tTG-IgA): Sensitivity 95%, Specificity 95%
• Total IgA level: To exclude IgA deficiency

Alternative/Additional tests:

• Endomysial antibody IgA (EMA-IgA): Highest specificity (>99%) but more expensive
• Deamidated gliadin peptide (DGP) IgA/IgG: Useful in IgA deficiency or children <2 years
• tTG-IgG and EMA-IgG: For IgA-deficient patients

Genetic Testing:

• HLA-DQ2/DQ8: High negative predictive value (>99%)
• Indications: Uncertain diagnosis, family screening, patients already on gluten-free diet

[HIGH_YIELD] Biopsy Requirements:

• Gold standard: Small bowel biopsy showing Marsh 2-3 lesions
• Location: Duodenal bulb and distal duodenum (at least 4-6 biopsies)
• Timing: Must be performed while on gluten-containing diet

Marsh Classification:

• Marsh 0: Normal mucosa
• Marsh 1: Increased intraepithelial lymphocytes (>25/100 epithelial cells)
• Marsh 2: Crypt hyperplasia + increased intraepithelial lymphocytes
• Marsh 3: Villous atrophy (3a: partial, 3b: subtotal, 3c: total)

[KEY_CONCEPT] Biopsy-sparing diagnosis may be considered in children with:

• tTG-IgA >10× upper limit of normal
• Positive EMA-IgA
• HLA-DQ2/DQ8 positive
• Symptomatic presentation

[KEY_CONCEPT] The gluten-free diet (GFD) is the only effective treatment for celiac disease and must be maintained lifelong. Successful management requires comprehensive patient education, dietary counseling, and long-term monitoring.

Gluten-Free Diet Fundamentals:

Foods to AVOID (contain gluten):

• Wheat (including spelt, kamut, farro, durum)
• Barley (including malt, malt extract, malt flavoring)
• Rye
• Triticale (wheat-rye hybrid)
• Oats (unless certified gluten-free due to cross-contamination)

Naturally Gluten-Free Foods:

• Grains: Rice, corn, quinoa, amaranth, millet, teff, certified gluten-free oats
• Proteins: Fresh meats, poultry, fish, eggs, legumes, nuts
• Dairy: Plain milk, cheese, yogurt
• Fruits and vegetables: All fresh, frozen, and canned varieties

[CLINICAL_PEARL] Cross-contamination is a major concern - even trace amounts of gluten (<20 ppm) can cause symptoms and intestinal damage in sensitive individuals.

Gluten-Free Diet Implementation Strategy:

Newly Diagnosed Patient | v

1. Immediate Gluten-Free Diet Initiation
   • No delay for additional testing
   • Refer to registered dietitian | v
2. Patient Education & Resources
   • Celiac support groups
   • Reading food labels
   • Cross-contamination prevention | v
3. Nutritional Assessment & Supplementation
   • Iron, B12, folate, vitamin D
   • Calcium screening
   • Consider multivitamin | v
4. Follow-up Schedule
   • 3-6 months: Clinical response
   • 6-12 months: Serology normalization
   • 12-24 months: Repeat biopsy (if indicated) | v
5. Long-term Monitoring
   • Annual nutritional assessment
   • Bone density screening
   • Cardiovascular risk assessment

Pharmacologic Considerations:

[HIGH_YIELD] Medication review is essential:

• Many medications contain gluten as excipients
• Prescription and OTC drugs should be verified gluten-free
• Supplements often contain gluten-containing fillers

Nutritional Supplementation:

• Iron: For iron deficiency anemia (most common deficiency)
• Vitamin D: 800-1000 IU daily
• Calcium: 1000-1200 mg daily
• B vitamins: Especially B12, folate, thiamine
• Fiber: GFD can be low in fiber

Monitoring Response to Treatment:

[CLINICAL_PEARL] Persistent symptoms on GFD may indicate:

• Inadvertent gluten exposure (most common cause)
• Non-celiac etiology of symptoms
• Refractory celiac disease (rare, <5%)
• Associated conditions (lactose intolerance, SIBO, IBS)

Special Populations:

• Children: Growth monitoring, delayed puberty assessment
• Pregnancy: Folate supplementation, nutritional counseling
• Elderly: Bone health, medication interactions

Emerging Therapies (investigational):

• Larazotide acetate: Zonulin receptor antagonist
• Transglutaminase inhibitors
• Gluten-degrading enzymes
• Immune modulators: Anti-IL-15 antibodies

[HIGH_YIELD] Untreated celiac disease can lead to serious complications affecting multiple organ systems. Early diagnosis and strict adherence to a gluten-free diet significantly reduces complication risk.

Acute Complications:

Celiac Crisis (rare, life-threatening):

• Severe malabsorption with electrolyte imbalances
• Profuse diarrhea and dehydration
• Hypoproteinemia and edema
• Management: IV fluids, electrolyte correction, nutritional support, immediate GFD

Nutritional Deficiencies:

• Iron deficiency anemia: Most common (>80% at diagnosis)
• Vitamin D deficiency: Leading to osteomalacia/rickets
• B vitamin deficiencies: B12, folate, thiamine
• Fat-soluble vitamin deficiencies: A, D, E, K

Chronic Complications:

[CLINICAL_PEARL] Malignancy risk is the most serious long-term complication, particularly enteropathy-associated T-cell lymphoma (EATL) and small bowel adenocarcinoma.

Malignant Complications:

Refractory Celiac Disease (RCD):

• Type I RCD: Normal intraepithelial lymphocytes, better prognosis
• Type II RCD: Aberrant intraepithelial lymphocytes, high malignancy risk (50%)
• Diagnosis: Persistent symptoms/histology despite >12 months strict GFD
• Management: Immunosuppression (corticosteroids, azathioprine), nutritional support

Bone Disease:

• Osteoporosis: 70% at diagnosis, improves with GFD
• Osteomalacia: Due to vitamin D/calcium malabsorption
• Growth retardation: In children
• Screening: DEXA scan at diagnosis, then every 1-2 years

[KEY_CONCEPT] Reproductive Complications:

• Female: Delayed menarche, amenorrhea, infertility, recurrent pregnancy loss
• Male: Hypogonadism, reduced sperm quality
• Pregnancy: Increased risk of intrauterine growth restriction, preterm delivery

Neurological Complications:

• Gluten ataxia: Progressive cerebellar dysfunction
• Peripheral neuropathy: Often irreversible
• Gluten encephalopathy: Cognitive dysfunction, headaches
• Epilepsy: Especially occipital calcifications

Cardiovascular Complications:

• Dilated cardiomyopathy: Rare, may improve with GFD
• Increased cardiovascular mortality: Related to chronic inflammation

Prognosis with Treatment:

[HIGH_YIELD] Excellent prognosis with strict gluten-free diet adherence:

• Symptom resolution: 70-80% within 6 months
• Histological healing: 70-80% within 2 years
• Malignancy risk: Approaches general population after 3-5 years of strict GFD
• Bone density: Significant improvement within 1-2 years

Factors Affecting Prognosis:

• Age at diagnosis: Better outcomes with earlier diagnosis
• Dietary adherence: Strict GFD essential
• Degree of histological damage: More severe damage takes longer to heal
• Associated autoimmune conditions: May complicate management

Monitoring Strategy:

Long-term Follow-up Schedule:

Year 1:

• Visits every 3-6 months
• Symptom assessment
• Serology monitoring
• Nutritional status

Years 2-5:

• Annual visits
• Serology normalization confirmation
• DEXA scan every 2 years
• Cardiovascular risk assessment

Lifelong:

• Annual celiac-focused visit
• Age-appropriate cancer screening
• Bone health monitoring
• Associated autoimmune condition screening

[CLINICAL_PEARL] Family screening is recommended for first-degree relatives due to 10% prevalence - start with serology testing every 2-3 years or if symptoms develop.